APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amiodarone Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Amiodarone Injection Industry Growth and Trends Forecast to 2032

2 January 2026106 pages

Choose your research edition.

Industry ResearchAmiodarone Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Amiodarone Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Amiodarone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amiodarone Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Amiodarone Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Amiodarone Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amiodarone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amiodarone Injection include AuroMedics, Bioniche Pharma, Hikma, Prism Pharmaceutical, Sagent, Baxter, Fangming Pharmaceutical Group, Fresenius Kabi and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Amiodarone Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amiodarone Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amiodarone Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amiodarone Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Amiodarone Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amiodarone Injection Market by Company

AuroMedics

Bioniche Pharma

Hikma

Prism Pharmaceutical

Sagent

Baxter

Fangming Pharmaceutical Group

Fresenius Kabi

Mylan

Sanofi

Amiodarone Injection Segment by Type

15mg/ml

50mg/ml

Amiodarone Injection Segment by Application

Clinics

Hospital

Recovery Center

Amiodarone Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amiodarone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amiodarone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amiodarone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amiodarone Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Amiodarone Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 15mg/ml Table 2. Major Company of 50mg/ml Table 3. Global Amiodarone Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Amiodarone Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Amiodarone Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Amiodarone Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Amiodarone Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Amiodarone Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Amiodarone Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Amiodarone Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Amiodarone Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Amiodarone Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Amiodarone Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Amiodarone Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Amiodarone Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Amiodarone Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Amiodarone Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Amiodarone Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Amiodarone Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Amiodarone Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Amiodarone Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Amiodarone Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Amiodarone Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Amiodarone Injection Industry Trends Table 25. Amiodarone Injection Industry Drivers Table 26. Amiodarone Injection Industry Opportunities and Challenges Table 27. Amiodarone Injection Industry Restraints Table 28. Global Amiodarone Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Amiodarone Injection Revenue Market Share by Company (2021-2026) Table 30. Global Amiodarone Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Amiodarone Injection Sales Share by Company (2021-2026) Table 32. Global Amiodarone Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Amiodarone Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Amiodarone Injection Major Company Production Sites and Headquarters Table 35. Global Amiodarone Injection Company, Product Type & Application Table 36. Global Amiodarone Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Amiodarone Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Amiodarone Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Amiodarone Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Amiodarone Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Amiodarone Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Amiodarone Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Amiodarone Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Amiodarone Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Amiodarone Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Amiodarone Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Amiodarone Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Amiodarone Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Amiodarone Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Amiodarone Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Amiodarone Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Amiodarone Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Amiodarone Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Amiodarone Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Amiodarone Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Amiodarone Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Amiodarone Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Amiodarone Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Amiodarone Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Amiodarone Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Amiodarone Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Amiodarone Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Amiodarone Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Amiodarone Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Amiodarone Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Amiodarone Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Amiodarone Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Amiodarone Injection Sales by Application (2021-2026) & (US$ Million) Table 71. AuroMedics Company Information Table 72. AuroMedics Business Overview Table 73. AuroMedics Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AuroMedics Amiodarone Injection Product Portfolio Table 75. AuroMedics Recent Development Table 76. Bioniche Pharma Company Information Table 77. Bioniche Pharma Business Overview Table 78. Bioniche Pharma Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bioniche Pharma Amiodarone Injection Product Portfolio Table 80. Bioniche Pharma Recent Development Table 81. Hikma Company Information Table 82. Hikma Business Overview Table 83. Hikma Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hikma Amiodarone Injection Product Portfolio Table 85. Hikma Recent Development Table 86. Prism Pharmaceutical Company Information Table 87. Prism Pharmaceutical Business Overview Table 88. Prism Pharmaceutical Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Prism Pharmaceutical Amiodarone Injection Product Portfolio Table 90. Prism Pharmaceutical Recent Development Table 91. Sagent Company Information Table 92. Sagent Business Overview Table 93. Sagent Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sagent Amiodarone Injection Product Portfolio Table 95. Sagent Recent Development Table 96. Baxter Company Information Table 97. Baxter Business Overview Table 98. Baxter Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Baxter Amiodarone Injection Product Portfolio Table 100. Baxter Recent Development Table 101. Fangming Pharmaceutical Group Company Information Table 102. Fangming Pharmaceutical Group Business Overview Table 103. Fangming Pharmaceutical Group Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Fangming Pharmaceutical Group Amiodarone Injection Product Portfolio Table 105. Fangming Pharmaceutical Group Recent Development Table 106. Fresenius Kabi Company Information Table 107. Fresenius Kabi Business Overview Table 108. Fresenius Kabi Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Fresenius Kabi Amiodarone Injection Product Portfolio Table 110. Fresenius Kabi Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mylan Amiodarone Injection Product Portfolio Table 115. Mylan Recent Development Table 116. Sanofi Company Information Table 117. Sanofi Business Overview Table 118. Sanofi Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sanofi Amiodarone Injection Product Portfolio Table 120. Sanofi Recent Development Table 121. North America Amiodarone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 123. North America Amiodarone Injection Sales Market Share by Country (2021-2026) Table 124. North America Amiodarone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Amiodarone Injection Sales Market Share Forecast by Country (2027-2032) Table 126. North America Amiodarone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Amiodarone Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Amiodarone Injection Market Share by Country (2021-2026) Table 129. North America Amiodarone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Amiodarone Injection Market Share Forecast by Country (2027-2032) Table 131. Europe Amiodarone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 133. Europe Amiodarone Injection Sales Market Share by Country (2021-2026) Table 134. Europe Amiodarone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Amiodarone Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Amiodarone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Amiodarone Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Amiodarone Injection Market Share by Country (2021-2026) Table 139. Europe Amiodarone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Amiodarone Injection Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Amiodarone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Amiodarone Injection Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Amiodarone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Amiodarone Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Amiodarone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Amiodarone Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Amiodarone Injection Market Share by Country (2021-2026) Table 149. Asia-Pacific Amiodarone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Amiodarone Injection Market Share Forecast by Country (2027-2032) Table 151. Latin America Amiodarone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 153. Latin America Amiodarone Injection Sales Market Share by Country (2021-2026) Table 154. Latin America Amiodarone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Amiodarone Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Amiodarone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Amiodarone Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Amiodarone Injection Market Share by Country (2021-2026) Table 159. Latin America Amiodarone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Amiodarone Injection Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Amiodarone Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Amiodarone Injection Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Amiodarone Injection Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Amiodarone Injection Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Amiodarone Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Amiodarone Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Amiodarone Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Amiodarone Injection Market Share by Country (2021-2026) Table 169. Middle East and Africa Amiodarone Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Amiodarone Injection Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Amiodarone Injection Distributors List Table 174. Amiodarone Injection Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Amiodarone Injection Image Figure 2. Global Amiodarone Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amiodarone Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Amiodarone Injection Sales (2021-2032) & (K Units) Figure 5. 15mg/ml Image Figure 6. Global 15mg/ml Sales YoY Growth (2021-2032) & (K Units) Figure 7. 50mg/ml Image Figure 8. Global 50mg/ml Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Amiodarone Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Amiodarone Injection Market Share by Type 2025 VS 2032 Figure 11. North America Amiodarone Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Amiodarone Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Amiodarone Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Amiodarone Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Amiodarone Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Amiodarone Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Amiodarone Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Amiodarone Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Amiodarone Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Amiodarone Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Amiodarone Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinics Image Figure 24. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Recovery Center Image Figure 28. Global Recovery Center Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Amiodarone Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Amiodarone Injection Market Share by Application 2025 VS 2032 Figure 31. North America Amiodarone Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Amiodarone Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Amiodarone Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Amiodarone Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Amiodarone Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Amiodarone Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Amiodarone Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Amiodarone Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Amiodarone Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Amiodarone Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Amiodarone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Amiodarone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Amiodarone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Amiodarone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Amiodarone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Amiodarone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Amiodarone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Amiodarone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Amiodarone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Amiodarone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Amiodarone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Amiodarone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Amiodarone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Amiodarone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Amiodarone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Amiodarone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Amiodarone Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Amiodarone Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Amiodarone Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Amiodarone Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Amiodarone Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Amiodarone Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg/ml
  • 50mg/ml
Applications
  • Clinics
  • Hospital
  • Recovery Center
Companies covered
  • AuroMedics
  • Bioniche Pharma
  • Hikma
  • Prism Pharmaceutical
  • Sagent
  • Baxter
  • Fangming Pharmaceutical Group
  • Fresenius Kabi
  • Mylan
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amiodarone Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Amiodarone Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Amiodarone Injection Market by Type
  6. 1.3.1 15mg/ml
  7. 1.3.2 50mg/ml
  8. 1.4 Global Amiodarone Injection Market Size by Type
  9. 1.4.1 Global Amiodarone Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Amiodarone Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Amiodarone Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Amiodarone Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Amiodarone Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Amiodarone Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Amiodarone Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Amiodarone Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Amiodarone Injection Industry Trends
  2. 2.2 Amiodarone Injection Industry Drivers
  3. 2.3 Amiodarone Injection Industry Opportunities and Challenges
  4. 2.4 Amiodarone Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Amiodarone Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Amiodarone Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Amiodarone Injection Price (2021-2026)
  4. 3.4 Global Amiodarone Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amiodarone Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Amiodarone Injection Company, Product Type & Application
  7. 3.7 Global Amiodarone Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amiodarone Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amiodarone Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amiodarone Injection Tier 1, Tier 2, and Tier 3
4 Amiodarone Injection Regional Status and Outlook
  1. 4.1 Global Amiodarone Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Amiodarone Injection Historic Market Size by Region
  3. 4.2.1 Global Amiodarone Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Amiodarone Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Amiodarone Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Amiodarone Injection Forecasted Market Size by Region
  7. 4.3.1 Global Amiodarone Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Amiodarone Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Amiodarone Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amiodarone Injection by Application
  1. 5.1 Amiodarone Injection Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Amiodarone Injection Market Size by Application
  6. 5.2.1 Global Amiodarone Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Amiodarone Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Amiodarone Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Amiodarone Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Amiodarone Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Amiodarone Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Amiodarone Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Amiodarone Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AuroMedics
  2. 6.1.1 AuroMedics Company Information
  3. 6.1.2 AuroMedics Business Overview
  4. 6.1.3 AuroMedics Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AuroMedics Amiodarone Injection Product Portfolio
  6. 6.1.5 AuroMedics Recent Developments
  7. 6.2 Bioniche Pharma
  8. 6.2.1 Bioniche Pharma Company Information
  9. 6.2.2 Bioniche Pharma Business Overview
  10. 6.2.3 Bioniche Pharma Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bioniche Pharma Amiodarone Injection Product Portfolio
  12. 6.2.5 Bioniche Pharma Recent Developments
  13. 6.3 Hikma
  14. 6.3.1 Hikma Company Information
  15. 6.3.2 Hikma Business Overview
  16. 6.3.3 Hikma Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Amiodarone Injection Product Portfolio
  18. 6.3.5 Hikma Recent Developments
  19. 6.4 Prism Pharmaceutical
  20. 6.4.1 Prism Pharmaceutical Company Information
  21. 6.4.2 Prism Pharmaceutical Business Overview
  22. 6.4.3 Prism Pharmaceutical Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Prism Pharmaceutical Amiodarone Injection Product Portfolio
  24. 6.4.5 Prism Pharmaceutical Recent Developments
  25. 6.5 Sagent
  26. 6.5.1 Sagent Company Information
  27. 6.5.2 Sagent Business Overview
  28. 6.5.3 Sagent Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sagent Amiodarone Injection Product Portfolio
  30. 6.5.5 Sagent Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Amiodarone Injection Product Portfolio
  36. 6.6.5 Baxter Recent Developments
  37. 6.7 Fangming Pharmaceutical Group
  38. 6.7.1 Fangming Pharmaceutical Group Company Information
  39. 6.7.2 Fangming Pharmaceutical Group Business Overview
  40. 6.7.3 Fangming Pharmaceutical Group Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Fangming Pharmaceutical Group Amiodarone Injection Product Portfolio
  42. 6.7.5 Fangming Pharmaceutical Group Recent Developments
  43. 6.8 Fresenius Kabi
  44. 6.8.1 Fresenius Kabi Company Information
  45. 6.8.2 Fresenius Kabi Business Overview
  46. 6.8.3 Fresenius Kabi Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fresenius Kabi Amiodarone Injection Product Portfolio
  48. 6.8.5 Fresenius Kabi Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Amiodarone Injection Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Amiodarone Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Amiodarone Injection Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Amiodarone Injection Sales by Country
  2. 7.1.1 North America Amiodarone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Amiodarone Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Amiodarone Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Amiodarone Injection Market Size by Country
  6. 7.2.1 North America Amiodarone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Amiodarone Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Amiodarone Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Amiodarone Injection Sales by Country
  2. 8.1.1 Europe Amiodarone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Amiodarone Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Amiodarone Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Amiodarone Injection Market Size by Country
  6. 8.2.1 Europe Amiodarone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Amiodarone Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Amiodarone Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Amiodarone Injection Sales by Country
  2. 9.1.1 Asia-Pacific Amiodarone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Amiodarone Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Amiodarone Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Amiodarone Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Amiodarone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Amiodarone Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Amiodarone Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Amiodarone Injection Sales by Country
  2. 10.1.1 South America Amiodarone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Amiodarone Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Amiodarone Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Amiodarone Injection Market Size by Country
  6. 10.2.1 South America Amiodarone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Amiodarone Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Amiodarone Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Amiodarone Injection Sales by Country
  2. 11.1.1 Middle East and Africa Amiodarone Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Amiodarone Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Amiodarone Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Amiodarone Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Amiodarone Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Amiodarone Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Amiodarone Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Amiodarone Injection Value Chain Analysis
  2. 12.1.1 Amiodarone Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Amiodarone Injection Production Mode & Process
  7. 12.2 Amiodarone Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Amiodarone Injection Distributors
  10. 12.2.3 Amiodarone Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst